US Market Access Marketing Team Lead Oncology

The US Market Access (USMA) Lead responsibilities include acting as the Senior Business Partner as well as leading a team of experienced market access professionals to establish market access in the US for a portfolio of inline and pre-approval assets. As a key USMA point-of-contact, this leader is connected into all aspects of US Market Access in the US such as Payer Access and Reimbursement, Channel Dynamics, Pricing, Contracting Strategy (Payer and Provider), and Hub or Patient Assistance. This leader has oversight responsibility and leadership for all facets related to leading, developing, and executing access strategies for the portfolio and products within the oncology portfolio.

This high-profile position will manage multiple direct reports, including marketing rotational colleagues. This position and corresponding team(s) will work collaboratively across various stakeholders, including USMA Leadership, GAV, and Brand Leadership. Through these responsibilities this leader is accountable for developing and attaining specified OP PLAN access targets as well as net sales attainment for their respective portfolios. This role will report to VP USMA Marketing and will maintain high connectivity to the US Franchise leads, US Business Unit Presidents (including representing Access within the Commercial Oncology Leadership Team), USMA leaders and USMA colleagues to ensure tight coordination and alignment within USMA of key initiatives and workstreams that affects the Oncology BU (OBU). This role will lead the Access agenda to accelerate and deliver priorities for both USMA and the Oncology Business Unit and will function as Strategic Partner with the Commercial business.  This leader will also ensure tight coordination and connectivity with Global Access Teams and will ensure high-functioning US Value & Access Teams.

This leader will function with a One Pfizer and One USMA mindset and will work across USMA functions to ensure a seamless partnership at all levels, but particularly with the senior executives in Commercial and the OBU. This colleague’s performance will be evaluated/incentivized in part based on the performance of the business they support and the outcome of P&L decisions, inputs, and outcomes.

This position will align to the Oncology Business Unit; Accountable for all therapeutics areas within the OBU. This includes 12 in line assets (and all subsequent indications) and ~8 pipeline assets in development, exclusive of any business development evaluations. Overall revenue impact 2025 is anticipated to be over $10B.

ROLE RESPONSIBILITIES  

• Collaboration: Co-develop strategy, trouble-shoot, problem-solve and triage where appropriate all access opportunities and issues related to associated Franchises. Will work closely with relevant USMA groups and own outcomes of associated work; effectively communicates with Sr. leadership (USMA, Brand at VP/President level and external customers) on variety of strategic topics (e.g. Access challenges, customer RFPs, formulary access changes, contracts) on a formal (OPPLAN) and ad hoc (e.g. customer issue) basis leading to patient and revenue goal development and attainment
• GTN & Forecasting: Advisor on Gross-to-Net implications through the Payer, Access, and Channel lens; provide input into budget forecasting based on key access drivers and steering the company through access challenges that impact GTN and forecasting
• Insight: Understands and evaluates the changing payer/access/channel environment across multiple therapeutic areas to proactively provide strategic implications and recommendations to key leaders in BUs; responds to customer and market needs while maintaining a deep understanding of payer & access customers and stakeholders including thought leadership on strategic tradeoffs to maximize the bottom line
• Strategy & Resources: Oversees development and execution of brand access strategies aligned to brand strategies and the needs of customers and the Account Teams; ensures timely and quality development of customer value platforms across portfolio, including the PVP and incorporating insights from access customers, PAM, PHI (e.g. HEOR), Customer Marketing, Strategy & Analytics, and other internal and external stakeholders
• Innovation: Integrates new and innovative solutions, including digital, to enhance Payer Customer engagement and value delivery
• Management Across Matrix Teams: Ensures tight alignment and execution between Global and US VATs; identifies business opportunities/challenges from the business to relevant USMA stakeholders and drives/leads meaningful impact back to the business; leads cross functional teams to align objectives and improve execution/evolution of access strategies and tactics
• Proce